Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

April 01, 1993; Volume 265,Issue 1
  • You have access
    Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats.
    S Yasar, C W Schindler, E B Thorndike, I Szelenyi and S R Goldberg
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 1-6;
  • You have access
    Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone.
    P Blier, A Lista and C De Montigny
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 7-15;
  • You have access
    Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins.
    P Blier, A Lista and C De Montigny
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 16-23;
  • You have access
    GM1 ganglioside treatment of focal ischemia: a dose-response and microdialysis study.
    R P Simon, J Chen and S H Graham
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 24-29;
  • You have access
    Antiproliferative and endothelium-dependent vasodilator properties of 1,3-dihydro-3-p-chlorophenyl-7-hydroxy-6-methyl-furo-(3,4c) pyridine hydrochloride (cicletanine).
    R D Bukoski, J Bo, H Xue and K Bian
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 30-35;
  • You have access
    Neurogenic vasodilation in the rat nasal mucosa involves neurokinin1 tachykinin receptors.
    G Piedimonte, J I Hoffman, W K Husseini, C Bertrand, R M Snider, M C Desai, G Petersson and J A Nadel
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 36-40;
  • You have access
    Induction of tolerance to crotoxin in mice.
    M Okamoto, L J Viskatis, G de la Roza and J C Vidal
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 41-46;
  • You have access
    Behavioral effects of pentobarbital, lorazepam, ethanol and chlorpromazine substitution in pentobarbital-dependent baboons.
    R J Lamb and R R Griffiths
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 47-52;
  • You have access
    Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.
    T S Shippenberg, R Bals-Kubik and A Herz
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 53-59;
  • You have access
    Mechanism of putrescine transport in human pulmonary artery endothelial cells.
    P P Sokol, K L Longenecker, D L Kachel and W J Martin
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 60-66;
  • You have access
    Somatostatin receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats.
    K Raynor, I Lucki and T Reisine
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 67-73;
  • You have access
    The volatile anesthetic isoflurane attenuates Ca++ mobilization in cultured vascular smooth muscle cells.
    J C Sill, S Eskuri, R Nelson, J Tarara and R A Van Dyke
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 74-80;
  • You have access
    Morphine-induced alterations in thymocyte subpopulations of B6C3F1 mice.
    D O Freier and B A Fuchs
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 81-88;
  • You have access
    Respiratory control of sympathetic nerve activity during naloxone-precipitated morphine withdrawal in rats.
    S C Baraban, R L Stornetta and P G Guyenet
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 89-95;
  • You have access
    Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats.
    M Million, J Fioramonti, S Gicquel, J M Zajac and L Bueno
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 96-102;
  • You have access
    Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
    A Colzi, F D'Agostini, A M Cesura, E Borroni and M Da Prada
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 103-111;
  • You have access
    In vitro and ex vivo inhibitory effects of L- and D-enantiomers of NG-nitro-arginine on endothelium-dependent relaxation of rat aorta.
    Y X Wang, C I Poon and C C Pang
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 112-119;
  • You have access
    Effects of drugs of abuse and cholinergic agents on delayed matching-to-sample responding in the squirrel monkey.
    T J Hudzik and G R Wenger
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 120-127;
  • You have access
    Acute opioid dependence in the cardiovascular system of the spinal rat.
    S L Cruz and J E Villarreal
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 128-133;
  • You have access
    Central mu opioid receptor-mediated changes in renal function in conscious rats.
    D R Kapusta, J C Obih and G F Dibona
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 134-143;
  • You have access
    Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. I. Pharmacokinetics after in vitro and in vivo exposure.
    L A Burns and A E Munson
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 144-149;
  • You have access
    Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. II. Nature and identification of reversing factors.
    L A Burns and A E Munson
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 150-158;
  • You have access
    Modulation of kainic acid-induced activity in the mouse spinal cord by the amino terminus of substance P: sensitivity to opioid antagonists.
    A A Larson and X Sun
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 159-165;
  • You have access
    Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains.
    C G Pick, R J Nejat and G W Pasternak
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 166-171;
  • You have access
    Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
    R E Tessel, D W Miller, G A Misse, X Dong and M B Doughty
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 172-177;
  • You have access
    Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55).
    L A Burns and A E Munson
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 178-186;
  • You have access
    Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
    T C Major, R W Overhiser, D G Taylor and R L Panek
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 187-193;
  • You have access
    Mechanism of the bradycardia produced in the cat by the anticholinesterase neostigmine.
    S B Backman, M Bachoo and C Polosa
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 194-200;
  • You have access
    (+-)-N6-endonorbornan-2-yl-9-methyladenine (N-0861) and its enantiomers: selective antagonists of A1-adenosine receptors in guinea pig isolated atria.
    P L Martin, A A Potts, A M Sykes and D G McKenna
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 201-206;
  • You have access
    Serotonergic involvement in haloperidol-induced catalepsy.
    B S Neal-Beliveau, J N Joyce and I Lucki
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 207-217;
  • You have access
    Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
    D R Compton, K C Rice, B R De Costa, R K Razdan, L S Melvin, M R Johnson and B R Martin
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 218-226;
  • You have access
    In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonist.
    R J Barrett, J M May, P L Martin and J R Miller
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 227-236;
  • You have access
    Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
    C Carpéné, J Galitzky, P Collon, F Esclapez, M Dauzats and M Lafontan
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 237-247;
  • You have access
    2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
    P L Martin, M Ueeda and R A Olsson
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 248-253;
  • You have access
    Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.
    J E Zadina, S L Chang, L J Ge and A J Kastin
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 254-262;
  • You have access
    Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase.
    Y X Wang and C C Pang
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 263-272;
  • You have access
    Secretin and somatostatin as modulators of electrolyte transport in guinea pig gallbladder epithelium.
    G Sprakties, H J Macherey and K U Petersen
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 273-280;
  • You have access
    N-aralkyl derivatives of 1-aminobenzotriazole as potent isozyme-selective mechanism-based inhibitors of rabbit pulmonary cytochrome P450 in vivo.
    J M Mathews and J R Bend
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 281-285;
  • You have access
    Pharmacologic characteristics of a medullary hyperalgesic center.
    S Parvini, S R Hamann and W R Martin
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 286-293;
  • You have access
    Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line.
    R J Lukas
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 294-302;
  • You have access
    5HT2 receptors mediate the effects of stress on the activity of periventricular hypophysial dopaminergic neurons and the secretion of alpha-melanocyte-stimulating hormone.
    J L Goudreau, J Manzanares, K J Lookingland and K E Moore
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 303-307;
  • You have access
    Epidermal growth factor and transforming growth factor-alpha directly inhibit parietal cell function through a similar mechanism.
    L Wang, M R Lucey, A M Fras, E J Wilson and J Del Valle
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 308-313;
  • You have access
    Opioid receptor regulation in mice.
    B C Yoburn, B Billings and A Duttaroy
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 314-320;
  • You have access
    Chronic physical activity alters hepatobiliary excretory function in rats.
    C A Yiamouyiannis, B J Martin and J B Watkins
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 321-327;
  • You have access
    An evaluation of an anti-inflammatory-histamine H2 antagonist drug complex on gastric erosions in the rat.
    T Imai, A Fukuhara, I Ueda and M Otagiri
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 328-333;
  • You have access
    Pharmacological characterization of the renovascular P2 purinergic receptors.
    P C Churchill and V R Ellis
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 334-338;
  • You have access
    Role of nitric oxide in neurogenic vasodilation of porcine cerebral artery.
    F Y Chen and T J Lee
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 339-345;
  • You have access
    Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
    R H Schwinger, M Böhm, C Schulz, U Schmidt, U Schmidt, B Schmid, H Dienemann, B Reichart and E Erdmann
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 346-357;
  • You have access
    Barbiturate anesthetics depress the resting K+ conductance of myocardium.
    J J Pancrazio, M J Frazer and C Lynch
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 358-365;
  • You have access
    Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
    A Berson, C Wolf, C Chachaty, C Fisch, D Fau, D Eugene, J Loeper, J C Gauthier, P Beaune and D Pompon
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 366-372;
  • You have access
    Serotonin-facilitated dopamine release in vivo: pharmacological characterization.
    S Benloucif, M J Keegan and M P Galloway
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 373-377;
  • You have access
    Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice.
    A A Alhaider and G L Wilcox
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 378-385;
  • You have access
    Inhibition and induction of cytochrome P450 isoenzymes in rat lung.
    R D Verschoyle, D Dinsdale and C R Wolf
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 386-391;
  • You have access
    Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: protection by fructose, cyclosporin A and trifluoperazine.
    R Imberti, A L Nieminen, B Herman and J J Lemasters
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 392-400;
  • You have access
    Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
    W Tassaneeyakul, D J Birkett, M E Veronese, M E McManus, R H Tukey, L C Quattrochi, H V Gelboin and J O Miners
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 401-407;
  • You have access
    Plasma stability and pharmacokinetics of radiolabeled deferoxamine-biotin derivatives.
    S F Rosebrough
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 408-415;
  • You have access
    Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591.
    P Tagari, A Becker, C Brideau, R Frenette, V Sadl, E Thomas, P Vickers and A Ford-Hutchinson
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 416-425;
  • You have access
    Sensitization of gamma-aminobutyric acid-induced depressions of cerebellar Purkinje neurons to the potentiative effects of ethanol by beta adrenergic mechanisms in rat brain.
    A M Lin, R K Freund and M R Palmer
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 426-432;
  • You have access
    Muscarinic m2 receptors in cerebellar granule cell cultures from rat: mechanism of short-term desensitization.
    J G Contrera, S W Mcleskey, I Holopainen, J Xu and W J Wojcik
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 433-440;
  • You have access
    Characterization of a decrease in muscarinic m2 mRNA in cerebellar granule cells by carbachol.
    P Longone, I Mocchetti, M A Riva and W J Wojcik
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 441-446;
  • You have access
    Thromboxane A2 stimulated signal transduction in vascular smooth muscle.
    G W Dorn and M W Becker
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 447-456;
  • You have access
    2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity.
    C W Benjamin, A H Lin, J Morris, D G Wishka and R R Gorman
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 457-462;
  • You have access
    Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats.
    T Gemba, M Ninomiya, K Matsunaga and M Ueda
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 463-467;
  • You have access
    Serotonin microinjected into the nucleus raphe obscurus increases intragastric pressure in the rat via a vagally mediated pathway.
    Z K Krowicki and P J Hornby
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 468-476;
  • You have access
    Induction of cytochrome P450 2B1 in rat liver by the aromatase inhibitor aminoglutethimide.
    M Murray, E Cantrill and G C Farrell
    Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 477-481;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 265, Issue 1
1 Apr 1993
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics